Gilead wins HIV patent manipulation suit but AIDS health group to appeal

For as long as Gilead Sciences has been making HIV and AIDS meds, it has been the target of AIDS groups over its pricing and availability of drugs. In the latest skirmish, the California company has brushed aside a lawsuit on a patent issue, but the healthcare group that accused it of anticompetitive practices says it will appeal and take the matter to the Supreme Court if necessary.  

ViiV Botswana tender win for dolutegravir a milestone

ViiV Healthcare has won its largest ever national tender for HIV therapy dolutegravir (Tivicay) in Botswana. The company expanded access to the therapy under the Medicines Patent Pool, which includes China manufacture by Shanghai-based Desano Pharmaceuticals.